Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1981 Mar;33(2):166–174.

Huntington disease and Tourette syndrome. I. Electron spin resonance of bed ghosts.

D E Comings, A Pekkala, J R Schuh, P C Kuo, S I Chan
PMCID: PMC1684941  PMID: 6259936

Abstract

Abnormalities in the electron spin resonance (ESR) of nitroxide-labeled red blood cell membranes have been reported in Huntington disease (HD). Because of the importance of verifying a general membrane defect in this disease, we have examined 13 unmedicated HD patients of all grades of severity, with a duration of symptoms from 3 to 20 years and including juvenile and rigid cases. No significance differences in the ESR of controls, HD patients, and three Tourette syndrome patients were found.

Full text

PDF
166

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abood M. E., Butler M. Membrane fluidity and fatty acid composition of phospholipids in erythrocyte membranes of patients with Huntington disease. J Neurosci Res. 1979;4(3):183–187. doi: 10.1002/jnr.490040305. [DOI] [PubMed] [Google Scholar]
  2. Aminoff M. J., Trenchard A., Turner P., Wood W. G., Hills M. Plasma uptake of dopamine and 5-hydroxytryptamine and plasma-catecholamine levels in patients with Huntington's chorea. Lancet. 1974 Nov 9;2(7889):1115–1116. doi: 10.1016/s0140-6736(74)90873-3. [DOI] [PubMed] [Google Scholar]
  3. Arlett C. F. Presymptomatic diagnosis of Huntington's disease? Lancet. 1980 Mar 8;1(8167):540–540. doi: 10.1016/s0140-6736(80)92790-7. [DOI] [PubMed] [Google Scholar]
  4. Barchi R. L. Physical probes of biological membranes in studies of the muscular dystrophies. Muscle Nerve. 1980 Jan-Feb;3(1):82–97. doi: 10.1002/mus.880030109. [DOI] [PubMed] [Google Scholar]
  5. Barkley D. S., Hardiwidjaja S., Menkes J. H. Abnormalities in growth of skin fibroblasts of patients with Huntington's disease. Ann Neurol. 1977 May;1(5):426–430. doi: 10.1002/ana.410010505. [DOI] [PubMed] [Google Scholar]
  6. Butterfield D. A., Braden M. L., Markesbery W. R. Erythrocyte membrane alterations in Huntington disease: effects of gamma-aminobutyric acid. J Supramol Struct. 1978;9(1):125–130. doi: 10.1002/jss.400090112. [DOI] [PubMed] [Google Scholar]
  7. Butterfield D. A., Chesnut D. B., Roses A. D., Appel S. H. Electron spin resonance studies of erythrocytes from patients with myotonic muscular dystrophy. Proc Natl Acad Sci U S A. 1974 Mar;71(3):909–913. doi: 10.1073/pnas.71.3.909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Butterfield D. A., Oeswein J. Q., Markesbery W. R. Electron spin resonance study of membrane protein alterations in erythrocytes in Huntington's disease. Nature. 1977 Jun 2;267(5610):453–455. doi: 10.1038/267453a0. [DOI] [PubMed] [Google Scholar]
  9. Butterfield D. A., Oeswein J. Q., Prunty M. E., Hisle K. C., Markesbery W. R. Increased sodium plus potassium adenosine triphosphatase activity in erythrocyte membranes in Huntington's disease. Ann Neurol. 1978 Jul;4(1):60–62. doi: 10.1002/ana.410040111. [DOI] [PubMed] [Google Scholar]
  10. Butterfield D. A., Roses A. D., Cooper M. L., Appel S. H., Chesnut D. B. A comparative electron spin resonance study of the erythrocyte membrane in myotonic muscular dystrophy. Biochemistry. 1974 Dec 3;13(25):5078–5082. doi: 10.1021/bi00722a003. [DOI] [PubMed] [Google Scholar]
  11. Cassiman J. J., Verlinden J., Vlietinck R. F., Bellemans J., Van Leuven F., Deroover J., Baro F., Van den Berghe H. Qualitative and quantitative study of the growth and cell surface properties of Huntington's disease fibroblasts and age-matched controls. Lack of significant differences. Hum Genet. 1979;53(1):75–86. doi: 10.1007/BF00289454. [DOI] [PubMed] [Google Scholar]
  12. Gaffney B. J., Drachman D. B., Lin D. C., Tennekoon G. Spin-label studies of erythrocytes in myotonic dystrophy: no increase in membrane fluidity. Neurology. 1980 Mar;30(3):272–276. doi: 10.1212/wnl.30.3.272. [DOI] [PubMed] [Google Scholar]
  13. Goetz I., Roberts E., Comings D. E. Fibroblasts in Huntington's disease. N Engl J Med. 1975 Dec 11;293(24):1225–1227. doi: 10.1056/NEJM197512112932403. [DOI] [PubMed] [Google Scholar]
  14. Gray P. N., Dana S. L. GABA synthesis by cultured fibroblasts obtained from persons with Huntington's disease. J Neurochem. 1979 Nov;33(5):985–992. doi: 10.1111/j.1471-4159.1979.tb05234.x. [DOI] [PubMed] [Google Scholar]
  15. Kirk D., Parrington J. M., Corney G., Bolt J. M. Anomalous cellular proliferation in vitro associated with Huntington's disease. Hum Genet. 1977 Apr 15;36(2):143–154. doi: 10.1007/BF00273252. [DOI] [PubMed] [Google Scholar]
  16. Leonardi A., De Martini I. S., Perdelli F., Mancardi G. L., Salvarani S., Bugiani O. Skin fibroblasts in Huntington's disease. N Engl J Med. 1978 Mar 16;298(11):632–632. doi: 10.1056/NEJM197803162981119. [DOI] [PubMed] [Google Scholar]
  17. Markesbery W. R., Butterfield D. A. Scanning electron microscopy studies of erythrocytes in Huntington's disease. Biochem Biophys Res Commun. 1977 Sep 23;78(2):560–564. doi: 10.1016/0006-291x(77)90215-7. [DOI] [PubMed] [Google Scholar]
  18. McLean D. R., Nihei T. Uptake of dopamine and 5-hydroxytryptamine by platelets from patients with Huntington's chorea. Lancet. 1977 Jan 29;1(8005):249–250. doi: 10.1016/s0140-6736(77)91037-6. [DOI] [PubMed] [Google Scholar]
  19. Menkes J. H., Hanoch A. Huntington's disease--growth of fibroblast cultures in lipid-deficient medium: a preliminary report. Ann Neurol. 1977 May;1(5):423–425. doi: 10.1002/ana.410010504. [DOI] [PubMed] [Google Scholar]
  20. Moshell A. N., Tarone R. E., Barrett S. F., Robbins J. H. Radiosensitivity in Huntington's disease: implications for pathogenesis and presymptomatic diagnosis. Lancet. 1980 Jan 5;1(8158):9–11. doi: 10.1016/s0140-6736(80)90550-4. [DOI] [PubMed] [Google Scholar]
  21. Noronha A. B., Roos R. P., Antel J. P., Arnason B. G. Huntington's disease: abnormality of lymphocyte capping. Ann Neurol. 1979 Nov;6(5):447–450. doi: 10.1002/ana.410060512. [DOI] [PubMed] [Google Scholar]
  22. Omenn G. S., Smith L. Platelet uptake of serotonin and dopamine in Huntington disease. Neurology. 1978 Mar;28(3):300–303. doi: 10.1212/wnl.28.3.300. [DOI] [PubMed] [Google Scholar]
  23. Pettegrew J. W., Nichols J. S., Stewart R. M. Studies of the fluorescence of fibroblasts from Huntington's disease: evidence of a membrane abnormality. N Engl J Med. 1979 Mar 22;300(12):678–678. doi: 10.1056/NEJM197903223001217. [DOI] [PubMed] [Google Scholar]
  24. Tourian A., Hung W. Glucosamine dependence of Huntington's chorea fibroblasts in culture. Biochem Biophys Res Commun. 1976 May 23;76(2):345–353. doi: 10.1016/0006-291x(77)90731-8. [DOI] [PubMed] [Google Scholar]
  25. Wherrett J. R., Brown B. L. Erythrocyte glycolipids in Huntington's chorea. Neurology. 1969 May;19(5):489–493. doi: 10.1212/wnl.19.5.489. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES